“Anti-PD-1 Immune Checkpoint Blockade-Based Therapy Using Pembrolizumab in a Patient With High-Grade Glioblastoma”. Biomedical Research and Therapy, vol. 10, no. 5, May 2023, pp. 5680-5, https://doi.org/10.15419/bmrat.v10i5.809.